KLF14 targets ITGB1 to inhibit the progression of cervical cancer via the PI3K/AKT signalling pathway
Lyu, XR; Ding, XC; Ye, H; Guo, R; Wu, MH; Cao, LL
Cao, LL (通讯作者),Shandong First Med Univ, Oncol Dept, Affiliated Hosp 1, Jinan 250014, Peoples R China.;Cao, LL (通讯作者),Shandong Prov Qianfoshan Hosp, Jinan 250014, Peoples R China.;Cao, LL (通讯作者),Shandong Univ, Shandong Prov Qianfoshan Hosp, Sch Med, Oncol Dept, Jinan 250014, Peoples R China.;Cao, LL (通讯作者),Shandong Prov Key Lab Rheumat Dis & Translat Med, Jinan 250014, Peoples R China.
DISCOVER ONCOLOGY, 2022; 13 (1):